January 13, 2025 - 19:16

Dan Mendelson, CEO of Morgan Health, shared his perspectives on the current state of the healthcare industry during a discussion at the JPMorgan Health Care Conference held in San Francisco. Mendelson emphasized the ongoing transformations within the sector, particularly in the realm of insurance and mergers and acquisitions.
He noted that the healthcare landscape is evolving rapidly, driven by technological advancements and changing consumer expectations. Mendelson highlighted the importance of innovation in improving patient outcomes and reducing costs, which remains a focal point for many organizations in the industry.
The conversation also touched upon the strategic moves being made by various players in the market. Mendelson pointed out that mergers and acquisitions are becoming increasingly common as companies seek to enhance their capabilities and expand their reach. He believes that these changes will ultimately lead to a more integrated and efficient healthcare system, benefiting both providers and patients alike.
Overall, Mendelson's insights reflect a dynamic and challenging environment in healthcare, with significant opportunities for growth and improvement on the horizon.
March 25, 2026 - 22:07
Department of Public Health Sciences celebrates 10th anniversary of undergraduate public health certificate programThe Department of Public Health Sciences at Clemson University is commemorating a significant milestone: the 10th anniversary of its undergraduate public health certificate program. This initiative...
March 25, 2026 - 14:28
Trump health vacancies offer chances to change courseFollowing a year marked by internal turbulence and public controversies, the administration is moving to fill key vacancies within the nation`s health agencies, signaling a desire for a more stable...
March 24, 2026 - 22:15
CVS Health and FTC Staff Agree to Proposed Insulin SettlementA significant development has emerged in the ongoing scrutiny of prescription drug costs, as a proposed agreement has been finalized between CVS Health and staff of the Federal Trade Commission....
March 24, 2026 - 13:03
Diverging Messages Reveal Potential Flaw in Trump's Drug Pricing StrategyA central pillar of the Trump administration`s plan to lower prescription drug costs involves pressuring other nations to pay more for medications, thereby reducing the financial burden on American...